Petition to the FDA to Strengthen Safety Warning for Botox and Related Drugs and Remove Misleading Claims From Botox/Botox Cosmetic Labeling December 12, 2023
Comments Regarding the Food and Drug Administration’s Notice of Proposed Rule on Medication Guides: Patient Medication Information (FDA-2019-N-5959) November 27, 2023
Testimony Before the FDA’s Meeting of the Pulmonary-Allergy Drugs Advisory Committee Regarding Gefapixant November 17, 2023
FDA Approval of the Delandistrogene Moxeparvovec-rokl (ELEVIDYS) Gene Therapy for Duchenne’s Muscular Dystrophy Calls into Question the Agency’s Role as a Careful Gatekeeper November 1, 2023
Testimony before the Food and Drug Administration’s Cellular, Tissue, and Gene Therapy Advisory Committee regarding Exagamglogene Autotemcel Gene Therapy for Sickle Cell Disease (BLA# 125787/0, Vertex Pharmaceuticals) October 31, 2023
Nearly 100 Organizations Show Their Support for Full Implementation of Medicare Negotiation Program September 28, 2023